logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Alzheimers Disease

    FiltersReset Filters
    7 results

    • donepezil

      (Donepezil hydrochloride)
      Quallent Pharmaceuticals Health LLC
      Usage: Donepezil hydrochloride tablets are indicated for treating Alzheimer's disease dementia, with proven efficacy in patients across mild, moderate, and severe stages.

    • galantamine

      (galantamine)
      TWi Pharmaceuticals USA, Inc.
      Usage: Galantamine tablets are indicated for treating mild to moderate Alzheimer's-type dementia.

    • kisunla

      (donanemab-azbt)
      Eli Lilly and Company
      Usage: KISUNLA™ is indicated for the treatment of Alzheimer's disease, specifically for patients with mild cognitive impairment or mild dementia, where clinical trials initiated treatment.

    • leqembi

      (lecanemab)
      Eisai Inc.
      Usage: LEQEMBI is indicated for treating Alzheimer's disease in patients with mild cognitive impairment or mild dementia, as these were the groups studied in clinical trials.

    • namzaric

      (memantine hydrochloride and donepezil hydrochloride)
      Allergan, Inc.
      Usage: NAMZARIC is indicated for treating moderate to severe Alzheimer's-type dementia in patients who are stabilized on a daily dose of 10 mg of donepezil hydrochloride.

    • tauvid

      (Flortaucipir F-18)
      Eli Lilly and Company
      Usage: TAUVID is indicated for PET imaging of the brain to estimate tau neurofibrillary tangles density in adult patients with cognitive impairment being evaluated for Alzheimer's disease. It is not indicated for chronic traumatic encephalopathy evaluation.

    • vizamyl

      (Flutemetamol F-18)
      Medi-Physics, Inc. dba GE Healthcare
      Usage: Vizamyl is indicated for PET imaging to estimate β-amyloid plaque density in adults with cognitive impairment, aiding in the evaluation of Alzheimer's Disease (AD) and other cognitive decline causes. It supports diagnostic evaluations but does not confirm a diagnosis or predict dementia progression.